Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.7%

2 terminated out of 26 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

12%

3 trials in Phase 3/4

Results Transparency

25%

5 of 20 completed with results

Key Signals

5 with results91% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (16)
P 1 (1)
P 2 (1)
P 3 (2)
P 4 (1)

Trial Status

Completed20
Unknown2
Terminated2
Enrolling By Invitation1
Recruiting1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT06765135Not ApplicableEnrolling By InvitationPrimary

Point of Care Respiratory Pathogen Testing for Antibiotic Stewardship in Primary Care

NCT06876259Not ApplicableRecruiting

Artificial Intelligence Diagnostic Decision Support to Reduce Antimicrobial Prescriptions in Young Children With Colds

NCT05035420Not ApplicableCompleted

A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases

NCT03365687Phase 3Completed

Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers

NCT06244615Not ApplicableCompleted

Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat

NCT02694679Not ApplicableCompleted

Randomized Controlled Trial of Social Network Targeting in Honduras

NCT05352581CompletedPrimary

BD Veritor™ At-Home and BD Veritor™ Professional

NCT03711292Not ApplicableCompleted

Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings

NCT05666752Not ApplicableUnknownPrimary

Effect of Intake of Allium Cepa L. Peel Heated Water Extract on Immunity Enhancement

NCT04468204Not ApplicableCompletedPrimary

Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory Infection (URI)

NCT02110732Not ApplicableCompletedPrimary

Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil

NCT00189475Phase 4CompletedPrimary

Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds

NCT04588376Not ApplicableCompletedPrimary

Improving Antibiotic Prescribing for Pediatric Respiratory Infections by Family Physicians With Peer Comparison

NCT02943551Not ApplicableUnknown

Dialogue Around Respiratory Illness Treatment

NCT03884777Completed

Incidence and Risk of Influenza in Myasthenic Patients

NCT00694421CompletedPrimary

Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2

NCT00405509CompletedPrimary

The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years

NCT01657643Not ApplicableCompletedPrimary

Effect of Probiotics on Health-related Quality of Life in College Students With Upper Respiratory Infections

NCT00642681Completed

Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

NCT01916031Not ApplicableCompletedPrimary

Appropriate Care of URI (ACURI): Early Head Start

Scroll to load more

Research Network

Activity Timeline